#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Corneal neovascularisation Hyperadrenocorticism Thrombocytosis Uveal melanoma Pulmonary alveolar haemorrhage Von Willebrand's disease Acute graft versus host disease in liver T-cell lymphoma Ocular myasthenia Diffuse large B-cell lymphoma refractory Myocarditis Follicle centre lymphoma follicular grade I II – III refractory Heavy menstrual bleeding Pleural mesothelioma malignant More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Lymphangioma – Basic Information Pulmonary fibrosis – Diagnostics Soft tissue sarcoma – Life with Disease Hepatoblastoma – Diagnostics Mucopolysaccharidosis II Chordoma – Treatment Lymphatic malformation – Trials in Disease Glycogen storage disease type V – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Soya Oil, Purified Tinzaparin Valiltramiprosate Ammonium Chloride Bp Paltusotine Phosphocreatine Sodium Technetium (99Mtc) Omeprazole Ds-3939A Docetaxel Iti-1284 Nitrous Oxide Cariprazine Hydrochloride Linagliptin Tiotropium Ezabenlimab Sodium Chloride TRV045 Befiradol (18F) Mifamurtide More therapies…

    Learn about Your Condition

    Follicular lymphoma Ophthalmoplegia Insomnia Lung disorder Hyponatraemia Neurodegenerative disorder Biopsy heart Malignant lymphoid neoplasm Myeloproliferative neoplasm Hairy cell leukaemia Rhinitis allergic Nodular melanoma Myelodysplastic syndrome Polymyositis Colon cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

    Not recruiting

    2 1
    Investigated Diseases:
    • Laparotomy
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    Germany
  • Study on Doxylamine and Pyridoxine for Pregnant Women with Nausea and Vomiting

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Morning sickness
    Investigated Drugs:
    • Doxylamine Hydrogen Succinate
    • Pyridoxine Hydrochloride
    Spain
  • Study on Juniper Berry Oil for Digestive Issues like Cramps, Gas, and Bloating in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • Juniper Berry Oil
    • Placebo
    Germany
  • Study of RVT-3101 for Treating Moderate to Severe Crohn’s Disease in Patients

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Pf-06480605
    • Ro7790121
    Belgium Bulgaria Czechia France Germany Hungary +5
  • Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Sacituzumab Govitecan
    Austria Germany
  • Study on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Czechia France Germany Greece +5
Previous Page
1 … 80 81 82 83 84 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!